NCT00380523View on ClinicalTrials.gov

Analgesic Treatment Mediated by Arcoxia (0663-093)

PHASE4CompletedINTERVENTIONAL

Enrollment

237

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Pain

Interventions

DRUG

MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00380523 - Analgesic Treatment Mediated by Arcoxia (0663-093) | Biotech Hunter | Biotech Hunter